You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Brain Metastasis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Metastases Trial in Tucson (18F-Fluciclovine PET/CT)

Not yet recruiting
  • Brain Metastases
  • 18F-Fluciclovine PET/CT
  • Tucson, Arizona
    Arizona Cancer Center at UMC North/University Medical Center
Sep 20, 2023

Brain Metastases, Brain Metastases, Adult, Brain Cancer Trial in Miami (18F fluciclovine)

Not yet recruiting
  • Brain Metastases
  • +2 more
  • 18F fluciclovine
  • Miami, Florida
    Miami Cancer Institute
Sep 15, 2023

Breast Cancer Trial in Xi'an (Disitamab Vedotin plus pyrotinib or naratinib)

Not yet recruiting
  • Breast Cancer
  • Disitamab Vedotin plus pyrotinib or naratinib
  • Xi'an, Shaanxi, China
    Xi'an International Medical Center Hospital
Aug 27, 2023

Brain Metastases, Radiosurgery Trial in Seoul (Magnetic resonance imaging (MRI), Diffusion-weighted MRI, Arterial spin labeling

Not yet recruiting
  • Brain Metastases
  • Radiosurgery
  • Magnetic resonance imaging (MRI)
  • +3 more
  • Seoul, Korea, Republic of
    Asan Medical Center
May 11, 2023

Brain Metastases, Radiation Necrosis Trial in Amiens (early 18F-FDOPA uptake)

Recruiting
  • Brain Metastases
  • Radiation Necrosis
  • early 18F-FDOPA uptake
  • Amiens, Picardie, France
    CHU Amiens
Mar 9, 2023

Breast Cancer Trial in Xi'an (Inetetamab plus pyrotiniband and capecitabine)

Active, not recruiting
  • Breast Cancer
  • Inetetamab plus pyrotiniband and capecitabine
  • Xi'an, Shaanxi, China
    Xi'an International Medical Center Hospital
Aug 27, 2023

Circulating Tumor DNA and T Cell Repertoire Predict

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Brain Metastases
  • Whole-brain radiotherapy
  • Wuhan, Hubei, China
    Union hospital
Feb 12, 2023

Brain Metastases Trial in Seoul (BT-M01)

Recruiting
  • Brain Metastases
  • BT-M01
  • Seoul, Song-pa Gu, Korea, Republic of
    Asan Medical Center
Oct 6, 2022

NSCLC, Renal Cell Carcinoma, Breast Carcinoma Trial (single fraction stereotactic radiosurgery (SSRS), fractionated stereotactic

Not yet recruiting
  • NSCLC
  • +5 more
  • single fraction stereotactic radiosurgery (SSRS)
  • fractionated stereotactic radiosurgery (FSRS)
  • (no location specified)
Jan 18, 2023

Brain Metastases, Brain Cancer Trial in Miami (18F-Fluciclovine)

Not yet recruiting
  • Brain Metastases
  • Brain Cancer
  • Miami, Florida
    Miami Cancer Institute at Baptist Health South Florida
Jan 3, 2023

Brain Metastases, Adult Trial in Rozzano (Silibinin)

Recruiting
  • Brain Metastases, Adult
  • Silibinin
  • Rozzano, Milano, Italy
    IRCCS Humanitas Research Hospital
Mar 20, 2023

Patients Receiving Radiation Therapy for Brain Metastases

Recruiting
  • Brain Metastasis
  • Cancer
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Brain Metastases Trial (MRI perfusion sequence)

    Not yet recruiting
    • Brain Metastases
    • MRI perfusion sequence
    • (no location specified)
    May 9, 2022

    Non Small Cell Lung Cancer Trial in Changsha (radiotherapy, Chemotherapy + immunotherapy)

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • radiotherapy
    • Chemotherapy + immunotherapy
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Oct 17, 2022

    Breast Tumors, Brain Tumors, Tumors by Site Trial (Abemaciclib, Elacestrant)

    Recruiting
    • Breast Neoplasms
    • +7 more
    • Canton, Ohio
      Gabrail Cancer Center
    Jan 24, 2023

    Brain Metastases, Adult, Non Small Cell Lung Cancer, Breast Cancer Trial in Messina, Rome, Turin (Silibinin, Placebo)

    Recruiting
    • Brain Metastases, Adult
    • +2 more
    • Silibinin
    • Placebo
    • Messina, Italy
    • +4 more
    Jan 9, 2023

    Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))

    Active, not recruiting
    • Breast Cancer
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Aug 15, 2022

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Diffusion and Perfusion MRI in Patients With Brain Metastasis

    Active, not recruiting
    • Brain Cancer
    • MRI
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Mar 15, 2022

    Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

    Recruiting
    • Melanoma
    • +14 more
    • LITT + Pembrolizumab
    • Gainesville, Florida
    • +1 more
    Aug 22, 2022

    NSCLC With EGFR Mutation, Brain Metastases Trial in China (Keynatinib)

    Recruiting
    • Non-Small Cell Lung Cancer With EGFR Mutation
    • Brain Metastases
    • Beijing, Beijing, China
    • +4 more
    Apr 17, 2022

    Breast Cancer, Brain Metastases Trial in Guangzhou (Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant)

    Recruiting
    • Breast Cancer
    • Brain Metastases
    • Palbociclib, Trastuzumab, Pyrotinib and Fulvestrant
    • Guangzhou, Guangdong, China
    • +1 more
    Apr 24, 2022

    Brain Tumors, Adult, Malignant Trial in Dallas (Stereotactic Radiosurgery)

    Recruiting
    • Brain Neoplasms, Adult, Malignant
    • Stereotactic Radiosurgery
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Feb 2, 2022

    Recurrent Brain Metastases, Progressive Brain Metastases Trial in United States (Meclofenamate)

    Active, not recruiting
    • Recurrent Brain Metastases
    • Progressive Brain Metastases
    • Miami, Florida
    • +6 more
    May 4, 2022

    Breast Tumor, Breast Carcinoma, Receptor, ErbB-2 Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)

    Recruiting
    • Breast Neoplasm
    • +2 more
    • 68GaNOTA-Anti-HER2 VHH1
    • Brussels, Belgium
      Uz Brussel
    Mar 4, 2022